أخبار المنتج يمكنك التحقق من أحدث معلومات المنتج
-
Launched Magicplex™ HSV 1/2 Amplification
Magicplex™ HSV 1/2 Amplification Simultaneous detection of Hepatitis A/B/C Using READ™ technology, this product simultaneously detects and discriminates between HSV 1 and HSV 2, on Real-time PCR. Herpes simplex Virus (HSV) Herpes simplex viruses 1 and 2 are two members of the herpes virus family, Herpesviridae, that infect humans. Both HSV 1 and 2 are ubiquitous and contagious. They lead to latent infection, recurring outbreaks, and permanent infection, and may cause pudendal and oral cancers. HSV 1 usually produces lesions on the face and in the mouth, and HSV 2 on the genitalia and the anus. Over 90% of adults carry the virus in a latent state, and over 80% of patients with cervical cancer occurring inside the vagina possess antibody for HSV 2. The main route of transmission for HSV 2 is sexual contact, and testing for HSV 2 infection may be considered as a step in preventing cervical cancer.
Feb 05, 2010｜ Magicplex HSV 1/2 Amplification
-
Launched Magicplex™ HSV 1/2 Real-Time Detection
Magicplex™ HSV 1/2 Real-Time Detection Simultaneous detection of HSV 1/2 Using READ™ technology, this product simultaneously detects and discriminates between HSV 1 and HSV 2, on Real-time PCR. Herpes simplex Virus (HSV) Herpes simplex viruses 1 and 2 are two members of the herpes virus family, Herpesviridae, that infect humans. Both HSV 1 and 2 are ubiquitous and contagious. They lead to latent infection, recurring outbreaks, and permanent infection, and may cause pudendal and oral cancers. HSV 1 usually produces lesions on the face and in the mouth, and HSV 2 on the genitalia and the anus. Over 90% of adults carry the virus in a latent state, and over 80% of patients with cervical cancer occurring inside the vagina possess antibody for HSV 2. The main route of transmission for HSV 2 is sexual contact, and testing for HSV 2 infection may be considered as a step in preventing cervical cancer.
Feb 05, 2010｜ Magicplex HSV 1/2 Real-Time Detection
-
Launched Magicplex™ MG/MH/UP Real-Time Test
Launched Magicplex™ MG/MH/UP Real-Time Test
Feb 04, 2010｜ Magicplex MG/MH/UP Real-Time Test
-
Launched Magicplex™ CT/NG Real-Time Detection
Launched Magicplex™ CT/NG Real-Time Detection
Feb 03, 2010｜ Magicplex CT/NG Real-Time Detection
-
Launched Magicplex™ STI 1 Amplification
Magicplex™ STI 1 Amplification Detection of 5 most common STI pathogens STI 1 Real-time Test, using READ™, amplifies the 5 most common pathogens that cause sexually transmitted inflammations in order to conduct the simultaneous tests by panels (Panel 1 (Chlamydia trachomatis, Neisseria gonorrhoeae) and Panel 2 (Mycoplasma genitalium, Mycoplasma hominis, Ureaplasma urealyticum)). C. trachomatis, N. gonorrhoeae, M. genitalium, M. hominis and U. urealyticum are the common causes of sexually-transmitted infections. Despite their high frequencies, most of cases are asymptomatic, which cause the delay of infection’s treatment and its eventual development into PID, ectopic pregnancy, infertility, chronic pelvic pain, cervicitis and urethritis. Magicplex™ STI 1 Real-time Test demonstrates a higher accuracy than the conventional diagnostic methods (e.g. Culture, Immuno assay, Conventional PCR, Real-time PCR) with reduction in test duration and additional test costs by Multiplex. It will be the perfect tool for preventing the spread of sexually transmitted diseases with rapid and accurate diagnosis.
Feb 02, 2010｜ Magicplex STI 1 Amplification
-
Obtained CE-IVD marking for Seeplex® CT ACE Detection
Seeplex® CT ACE Detection Seegene's Seeplex® CT ACE Detction has been notified at Germany CA (Competent Authorities). The CE mark will allow more opportunities for Seegene to market and sell within the European Union.
Jan 01, 2010｜ Seeplex® CT ACE Detection
-
Obtained CE-IVD marking for Allplex™ Bacterial Vaginosis Assay
Allplex™ Bacterial Vaginosis Assay simultaneously detects 7 bacteria (G. vaginalis, A. vaginae, Megasphaera type 1, BV-associated bacteria 2, Mobiluncus spp., B. fragilis, Lactobacillus spp.) associated with vaginosis. It provides quantitative information of 3 major bacteria (G. vaginalis, A. vaginae, Lactobacillus spp.). Based on Seegene’s proprietary MuDT™ technology, this assay makes it possible to report individual Ct value of multiple bacteria in a single channel. The CE-IVD mark will allow more opportunities for Seegene to market and sell within the European Union.
Dec 15, 2009｜ Allplex™ Bacterial Vaginosis Assay
-
Obtained CE-IVD marking for Seeplex® HSV2 ACE Detection
Detection of HSV1 & HSV2Seegene's Seeplex® HSV2 ACE Detection has been notified at Germany CA (Competent Authorities). The CE mark will allow more opportunities for Seegene to market and sell within the European Union.
Nov 27, 2009｜ Seeplex® HSV2 ACE Detection